CMS Announced New Hospital Procedure Codes For Therapeutics - PowerPoint PPT Presentation

About This Presentation
Title:

CMS Announced New Hospital Procedure Codes For Therapeutics

Description:

The emergence of coronavirus disease 2019 (COVID19) and the new treatments that have followed, to track the use of treatments is critical and their effectiveness is real time. The CMS responded this need, and in record time is implementing new procedure codes to allow Medicare and other insurers to identify the use of the therapeutics remdesivir and convalescent plasma for treating hospital in-patients with COVID-19. – PowerPoint PPT presentation

Number of Views:5
Slides: 7
Provided by: richardssmith2018
Category:

less

Transcript and Presenter's Notes

Title: CMS Announced New Hospital Procedure Codes For Therapeutics


1
  • CMS Announced New Hospital Procedure Codes For
    Therapeutics

2
CMS Announced New Hospital Procedure Codes For
Therapeutics
The emergence of coronavirus disease 2019
(COVID19) and the new treatments that have
followed, to track the use of treatments is
critical and their effectiveness is real time.
The CMS responded this need, and in record time
is implementing new procedure codes to allow
Medicare and other insurers to identify the use
of the therapeutics remdesivir and convalescent
plasma for treating hospital in-patients with
COVID-19. These new codes will be effective from
August 1, and these will enable CMS to conduct
real-time surveillance and obtain real-world
evidence in how these drugs are working and
provide critical information on their usefulness
and how they can protect patients. These new
codes are helpful to report to Medicare and other
insurers may also use the codes to identify the
use of COVID19 therapies. This also help to
facilitate monitoring and data collection on
their use. These new codes are being implemented
into the International Classification of
Diseases, Tenth Revision, Procedure Coding System
(ICD-10-PCS). ICD-10-PCS is the Health Insurance
Portability and Accountability Act (HIPAA)
designated code set for reporting hospital
inpatient procedures, which is developed and
maintained by CMS and can be used by other health
insurers. The implementation of these new
procedure codes is part of the Trump
Administrations ongoing efforts to protect the
health and safety of COVID-19 patients across the
country during the public health emergency.
3
CMS Announced New Hospital Procedure Codes For
Therapeutics
Assignment of the new ICD-10-PCS procedure codes
is as follows Procedure Code XW013F5 Introduction
of Other New Technology Therapeutic Substance
into Subcutaneous Tissue, Percutaneous Approach,
New Technology Group 5. Procedure Code
XW033E5 Introduction of Remdesivir Anti-infective
into Peripheral Vein, Percutaneous Approach, New
Technology Group 5 Procedure Code
XW033F5 Introduction of Other New Technology
Therapeutic Substance into Peripheral Vein,
Percutaneous Approach, New Technology Group
5 Procedure Code XW033G5 Introduction of
Sarilumab into Peripheral Vein, Percutaneous
Approach, New Technology Group 5 Procedure Code
XW033H5 Introduction of Tocilizumab into
Peripheral Vein, Percutaneous Approach, New
Technology Group 5
4
CMS Announced New Hospital Procedure Codes For
Therapeutics
Procedure Code XW043E5 Introduction of Remdesivir
Anti-infective into Central Vein, Percutaneous
Approach, New Technology Group 5 Procedure Code
XW043F5 Introduction of Other New Technology
Therapeutic Substance into Central Vein,
Percutaneous Approach, New Technology Group
5 Procedure Code XW043G5 Introduction of
Sarilumab into Central Vein, Percutaneous
Approach, New Technology Group 5 Procedure Code
XW043H5 Introduction of Tocilizumab into Central
Vein, Percutaneous Approach, New Technology Group
5 Procedure Code XW0DXF5 Introduction of Other
New Technology Therapeutic Substance into Mouth
and Pharynx, External Approach, New Technology
Group 5
5
CMS Announced New Hospital Procedure Codes For
Therapeutics
Procedure Code XW13325 Transfusion of
Convalescent Plasma (Nonautologous) into
Peripheral Vein, Percutaneous Approach, New
Technology Group 5 Procedure Code
XW14325 Transfusion of Convalescent Plasma
(Nonautologous) into Central Vein, Percutaneous
Approach, New Technology Group 5 As the
procedure codes are designated as non-O.R.
procedures, there is no assigned MDC or MS-DRG.
The ICD-10 MS-DRG assignment is dependent on the
reported principal diagnosis, any secondary
diagnoses defined as a complication or
comorbidity (CC) or major complication or
comorbidity (MCC), procedures or services
performed, age, sex, and discharge status. Are
You Ready To Get Billing? Want to overcome
healthcare revenue cycle challenges? You are at
the right place, what you need now is a partner
who can finish out the rest of the work and make
the technology and implementation just as simple.
Thats what the best medical billing company like
Medisys Data Solutions Inc can do. If youre
ready to get started, schedule a meeting with our
medical billing manager from filling out enquiry
form from our website!
6
CMS Announced New Hospital Procedure Codes For
Therapeutics
Get more information at The ICD-10 MS-DRG V37.2
Grouper Software, Definitions Manual Table of
Contents and the Definitions of Medicare Code
Edits V37.2 manual The Code Tables, Index and
related Addenda files for the 12 new procedure
codes
Write a Comment
User Comments (0)
About PowerShow.com